Table 1.
Study | n | Age (years) |
NYHA class (mean) |
NYHA class≥III (%) |
LVEF (%) |
Baseline NP (pg/mL) |
Treatment goal (pg/mL) |
---|---|---|---|---|---|---|---|
BNP | |||||||
Murdoch | 20 | 64/62 | 2.4/2.5 | NA | 25/25 | 139/111 pg/mL (mean) | <50 |
STARS-BNP | 220 | 66/65 | 2.2/2.3 | 21/29 | 32/30 | NA/352 (mean) | <100 |
NTproBNP | |||||||
Troughton | 69 | 68/72 | 2.3/2.3 | 28/33 | 28/26 | 1835/2122 | <1700 |
TIME-CHF | 499 | 77/76 | NA | 75/74 | 30/30 | 4657/3998 (median) | <400 (60-74 years) <800 (≥75 years) |
BATTLESCARRED | 364 | 76-77 (median) | ∼2.2 | 24 | 37 | 1997-2021 (median) | <1300 |
Values are given for control group/hormone guided group or for groups combined. BATTLESCARRED consisted of three groups.